Using Ozempic or Wegovy could raise risk for rare form of blindness, study suggests
People who use Ozempic or Wegovy for treating obesity or Type 2 diabetes may have an increased risk of developing a rare form of blindness, according to a study published Wednesday in the journal JAMA Ophthalmology, which Novo Nordisk has criticised for being insufficient. Key Facts Chief Critic Novo Nordisk said in a statement the […]
